Assessing Changes in Motor Function and Mobility in Individuals with Parkinson’s Disease
Study Overview
This study looked at how 12 sessions of patient-specific adaptive dynamic cycling (PSADC) compared to non-adaptive cycling (NA) affected motor function and mobility in people with Parkinson’s disease (PD). We used advanced sensors to measure changes accurately.
Methodology
Twenty-three participants with PD took part in the study over 4 weeks. Thirteen were in the PSADC group and ten in the NA group. We measured motor function with Kinesia sensors and the MDS-UPDRS Motor III scale, while mobility was assessed using the TUG test with OPAL IMU sensors.
Key Findings
The PSADC group showed significant improvements in motor function and dopamine-sensitive symptoms, while the NA group did not see any improvements. Both groups had minor improvements in TUG time, but these were not statistically significant. The IMU sensors provided continuous and unbiased data, allowing for precise tracking of progress.
Conclusions
PSADC was more effective in improving motor function in PD patients compared to NA. The use of IMU sensors was crucial for accurate monitoring, highlighting the benefits of a personalized exercise approach to enhance treatment outcomes for individuals with PD.
Importance of Clinical Trials
Clinical trials are essential for developing safe and effective treatments. To make these benefits available in everyday healthcare, we offer DocSym, an AI-driven platform that combines ICD-11 standards, clinical protocols, and research into one easy-to-use resource for clinicians.
Streamlining Healthcare Operations
In today’s healthcare landscape, efficiency is vital. Our mobile apps assist with scheduling, treatment monitoring, and telemedicine, simplifying patient care management and expanding digital services.
Enhancing Patient Outcomes
By leveraging AI, clinics can improve workflows, enhance patient outcomes, and reduce reliance on paper processes. Discover how we can assist you at aidevmd.com.
